Bill could provide a major boost for cannabis research as more cultivators are set to receive licensing approval.
With opioid use disorder (OUD) claiming more lives every year in the U.S., research into the possibility of using cannabis as a therapeutic tool to tackle opioid addiction becomes ever more critical.
N-propane could be on track to provide a cheaper and easier-to-use alternative to carbon dioxide as a solvent for the process of extracting hemp oil from seeds.
Research has found cannabis users have a higher resting cortical activity compared to non-users, possibly impairing cognitive processes and the ability to make decisions.
With the legalization of cannabis use in Canada looming, concerns are increasing over the risks associated with admitting association with the drug when crossing U.S. border.
Terpenes are the relatively unresearched molecules present in cannabis products. Unlocking their potential could provide a whole new array of cannabis uses and benefits.
Ginko Bioworks and Cronos partner to facilitate the future production of lab-grown cannabis.
A new system is being introduced to allow black and gray market cannabis producers to introduce and protect their unique cannabis strains in the Canadian cannabis market.
The authors behind the work believe that CBD may constitute an excellent candidate for the treatment of MS and other autoimmune diseases as a novel, non-psychoactive therapeutic.